Recombinant Human PDGF-AA and 7 more items

The University of Virginia issued purchase order A207_PO-0450227 to Quartzy on June 19, 2026, for a cumulative contract value of $1,227.05. The award encompasses eight line items consisting of laboratory reagents, biological products, and surgical instruments. Deliveries are directed to Stef Gunst and include recombinant human proteins (Platelet-Derived Growth Factor-AAand Fibroblast Growth Factor-basic), monoclonal antibodies (anti-mouse CD16/CD32), immunoglobulins (Rat Gamma Globulin), peroxiredoxin antibody, surface disinfectant, and surgical forceps. The products span research-grade biological materials and laboratory consumables typical of academic research environments.

This Virginia-based contract represents a small-value procurement supporting the University of Virginia's research and laboratory operations. The product mix—combining molecular biology reagents, immunological materials, and precision surgical instruments—suggests delivery to research laboratories or medical facilities within the institution. No specific period of performance is delineated in the contract documentation; however, the single-unit quantities across most line items indicate this constitutes a one-time procurement of laboratory supplies and equipment rather than a recurring supply agreement. The award date of June 19, 2026, reflects the execution date of the purchase order.